|
In 2016, the total size of the market of guangdong provincial grade hospital in 2016 was 93.703 billion yuan, a 9.5% increase from 2015. But the proportion of Chinese drugs in China fell in 2016 from 2015 and was the lowest in two years in 2016. Challenges and opportunities are in parallel, and the top 100 varieties of the guangdong grade hospital market are available for reference in 2016.
Note: the data of this ranking are all derived from the CMH drive system.
The total size of the market in guangdong's grade hospital in 2016 was 93.703 billion yuan, a 9.5 percent increase from 2015. From each quarter rose, although at the end of first quarter, the fourth quarter, the Spring Festival and other factors affect the retreat, but 2016 annual guangdong province level hospital market overall 9.5% of good growth, especially in q2 2016 rose to 11.7%, is the main power drive annual growth.
Due to the frequent adverse reaction events of traditional Chinese medicine injection, the Chinese medicine has been affected to some extent in the market of guangdong grade hospital in 2016. In terms of the proportion of Chinese and western medicine, the proportion of chemical medicine is four times that of Chinese medicine, and the proportion of Chinese medicine has decreased in 2016 compared with 2015. From the quarter to quarter, the proportion of Chinese medicine was higher than the second and third quarters in the first and fourth quarters, and the lowest value in two years in 2016.
In 2016, the top 100 sales of guangdong provincial level hospitals were 33.488 billion yuan, up 11.9% from the 2015 TOP100, accounting for 35.7% of guangdong's total. Of the TOP100 varieties, there were 89 chemicals and only 11 of them. In terms of indications, there were 25 varieties of full-body anti-infective drugs, followed by anti-tumor and immunomotics and cardiovascular drugs. There are 10 varieties of nervous system drugs, 7 varieties of digestive system and metabolites, 6 varieties of blood and hematopoietic system... TOP10 variety center vascular system drugs, blood and hematopoietic system drugs all occupy 3 seats. Top is sodium chloride injection (sales of 1.083 billion yuan, 1.16%), followed by the creatine phosphate sodium for injection (922 million, 0.98%), proprietary Chinese medicine is the highest ranked Kang Yi injection (375 million, 0.40%).
|
